Shashi Rajput

1.2k citations

23 papers · 936 indexed · h-index 19

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 3
Complementary and alternative medicine top 2%
- Nigella sativa pharmacological applications 5
- Natural Compounds in Disease Treatment 2
Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 6
Molecular Medicine top 10%
Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 2
Biomedical Engineering
- Nanoplatforms for cancer theranostics 7
Molecular Biology
- Cell death mechanisms and regulation 3
- Advanced biosensing and bioanalysis techniques 2

Co-authors: Mahitosh Mandal B. N. Prashanth Kumar Nagaprasad Puvvada Siddik Sarkar Amita Pathak Paul B. Fisher Kaushik Dey Aditya Parekh
Cited by: Toxicology Complementary and alternative medicine Biomaterials
Journals: PLoS ONE (1 paper)Langmuir (1 paper)Oncogene (1 paper)
Partner nations: India United States Canada

In The Last Decade

Shashi Rajput

23 papers receiving 920 citations

Peers

Countries citing papers authored by Shashi Rajput

Since Specialization

Citations

This map shows the geographic impact of Shashi Rajput's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashi Rajput with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashi Rajput more than expected).

Fields of papers citing papers by Shashi Rajput

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashi Rajput. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashi Rajput. The network helps show where Shashi Rajput may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shashi Rajput, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shashi Rajput Line = papers co-authored together Shashi Rajput links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer Molecular Pharmaceutics ·B. N. Prashanth Kumar,Nagaprasad Puvvada,Shashi Rajput,Siddik Sarkar,Madhusudan Kr. Mahto,Murali M. Yallapu,Amita Pathak,Luni Emdad,Swadesh K. Das,Rui L. Reis,Subhas C. Kundu,Paul B. Fisher,Mahitosh Mandal	2018	27
2	Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment Langmuir ·Siddik Sarkar,Suraj Konar,Nagaprasad Puvvada,Shashi Rajput,B. N. Prashanth Kumar,Raj R. Rao,Amita Pathak,Paul B. Fisher,Mahitosh Mandal	2017	36
3	BI2536 – A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells Biomedicine & Pharmacotherapy ·B. N. Prashanth Kumar,Shashi Rajput,Rashmi Bharti,Sheetal Parida,Mahitosh Mandal	2015	21
4	Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer Oncogene ·Rashmi Bharti,Goutam Dey,Probir Kumar Ojha,Shashi Rajput,Saravana Kumar Jaganathan,Ramkrishna Sen,Mahitosh Mandal	2015	63
5	Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression Scientific Reports ·Nagaprasad Puvvada,Shashi Rajput,B. N. Prashanth Kumar,Siddik Sarkar,Suraj Konar,Keith R. Brunt,Raj R. Rao,Abhijit Mazumdar,Swadesh K. Das,Ranadhir Basu,Paul B. Fisher,Mahitosh Mandal,Amita Pathak	2015	72
6	Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach Tumor Biology ·Kaushik Dey,Ipsita Pal,Rashmi Bharti,Goutam Dey,B. N. Prashanth Kumar,Shashi Rajput,Aditya Parekh,Sheetal Parida,Priyanka Halder,Indranil Kulavi,Mahitosh Mandal	2015	18
7	Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes Molecular Pharmaceutics ·Shashi Rajput,Nagaprasad Puvvada,B. N. Prashanth Kumar,Siddik Sarkar,Suraj Konar,Rashmi Bharti,Goutam Dey,Abhijit Mazumdar,Amita Pathak,Paul B. Fisher,Mahitosh Mandal	2015	62
8	Thymoquinone Restores Radiation‐Induced TGF‐β Expression and Abrogates EMT in Chemoradiotherapy of Breast Cancer Cells Journal of Cellular Physiology ·Shashi Rajput,B. N. Prashanth Kumar,Payel Banik,Sheetal Parida,Mahitosh Mandal	2014	45
9	BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt British Journal of Cancer ·Ipsita Pal,Siddik Sarkar,Shashi Rajput,Kaushik Dey,Sayan Chakraborty,Rupesh Dash,Swadesh K. Das,Devanand Sarkar,Elisa Barile,Surya K. De,Maurizio Pellecchia,Paul B. Fisher,Mahitosh Mandal	2014	10
10	Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer PLoS ONE ·Shashi Rajput,B. N. Prashanth Kumar,Siddik Sarkar,Subhasis Das,Belal Azab,Prasanna K. Santhekadur,Swadesh K. Das,Luni Emdad,Devanand Sarkar,Paul B. Fisher,Mahitosh Mandal	2013	104
11	Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells Molecular Cancer ·Siddik Sarkar,Shashi Rajput,Amit Kumar Tripathi,Mahitosh Mandal	2013	18
12	Frequency dependent impedimetric cytotoxic evaluation of anticancer drug on breast cancer cell Biosensors and Bioelectronics ·Rangadhar Pradhan,Shashi Rajput,Mahitosh Mandal,Analava Mitra,Soumen Das	2013	27
13	Electric cell–substrate impedance sensing technique to monitor cellular behaviours of cancer cells RSC Advances ·Rangadhar Pradhan,Shashi Rajput,Mahitosh Mandal,Analava Mitra,Soumen Das	2013	19
14	Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells Life Sciences ·Shashi Rajput,B. N. Prashanth Kumar,Kaushik Dey,Ipsita Pal,Aditya Parekh,Mahitosh Mandal	2013	108
15	Photoresponsive Coumarin-Tethered Multifunctional Magnetic Nanoparticles for Release of Anticancer Drug ACS Applied Materials & Interfaces ·Karthik Sambath,Nagaprasad Puvvada,B. N. Prashanth Kumar,Shashi Rajput,Amita Pathak,Mahitosh Mandal,N. D. Pradeep Singh	2013	79
16	Exploring the fluorescence switching phenomenon of curcumin encapsulated niosomes: in vitro real time monitoring of curcumin release to cancer cells RSC Advances ·Nagaprasad Puvvada,Shashi Rajput,B. N. Prashanth Kumar,Mahitosh Mandal,Amita Pathak	2013	25
17	Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling BMC Cancer ·B. N. Prashanth Kumar,Shashi Rajput,Kaushik Dey,Aditya Parekh,Subhasis Das,Abhijit Mazumdar,Mahitosh Mandal	2013	60
18	201 Combinatorial Effect of ZD6474 and Thymoquinone Inhibits Src Mediated ERK-1/2/STAT3 Signalling and Renders Antimetastasis in Breast Cancer European Journal of Cancer ·Shashi Rajput,Kaushik Dey,P. Ipsita,Koushik Sen,Goutam Dey,Rashmi Bharti,Sheetal Parida,Aditya Parekh,Mahitosh Mandal	2012	1
19	Antitumor promoting potential of selected phytochemicals derived from spices European Journal of Cancer Prevention ·Shashi Rajput,Mahitosh Mandal	2011	70
20	Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma. PubMed ·Kruttibas Sethi,Siddik Sarkar,Subhasis Das,Shashi Rajput,Abhijit Mazumder,Bhaskar Roy,Susmita Patra,Biswanarayan Mohanty,Adel K. El‐Naggar,Mahitosh Mandal	2011	21

About Shashi Rajput

Shashi Rajput is a scholar working on Toxicology, Complementary and alternative medicine and Biomaterials, having authored 23 papers that have together received 936 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Nigella sativa pharmacological applications (5 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cell death mechanisms and regulation (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Natural Compounds in Disease Treatment (2 papers). The work is most often cited by research in Toxicology (136 citations), Complementary and alternative medicine (198 citations) and Biomaterials (171 citations). Shashi Rajput has collaborated with scholars based in India, United States and Canada. Frequent co-authors include Mahitosh Mandal, B. N. Prashanth Kumar, Nagaprasad Puvvada, Siddik Sarkar, Amita Pathak, Paul B. Fisher, Kaushik Dey, Aditya Parekh, Ipsita Pal and Abhijit Mazumdar. Their work appears in journals such as PLoS ONE, Langmuir and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact